These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3035868)

  • 1. [Autoradiography of [3H]ohmefentanyl binding with opiate receptors in the rat brain].
    Ye SZ; Li GF; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):193-8. PubMed ID: 3035868
    [No Abstract]   [Full Text] [Related]  

  • 2. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
    Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
    Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoradiographic distribution of [3H]ohmefentanyl binding sites in rat corpus striatum].
    Yao YH; Xu H; Li GF; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1988 May; 9(3):212-5. PubMed ID: 2850709
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preparation of [3H]-labelled N-[1-(beta-hydroxy beta-phenylethyl)-3-methyl-4-piperidyl]-N-phenylpropionamide and studies of its binding with opiate receptors of mouse brain].
    Zhou DH; Ni CH; Wu YZ; Li ZY; Liu JZ; Tang GZ; Zhao XL
    Yao Xue Xue Bao; 1982 Sep; 17(9):658-62. PubMed ID: 6297237
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain.
    Fitzgerald LW; Teitler M
    Synapse; 1993 Jun; 14(2):154-9. PubMed ID: 8392757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro binding properties of 3H-sufentanil, a superior ligand for the mu-opiate receptor.
    Leysen JE; Gommeren W
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):287-9. PubMed ID: 6131653
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding sites of mu receptor increased when acupuncture analgesia was enhanced by droperidol: an autoradiographic study.
    Zhu CB; Li XY; Zhu YH; Xu SF
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):311-4. PubMed ID: 7668098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of peptides and morphine-like narcotic analgesics with specifically labelled mu- and delta-opiate receptor binding sites.
    Hermans B; Gommeren W; De Potter WP; Leysen JE
    Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):317-9. PubMed ID: 6136260
    [No Abstract]   [Full Text] [Related]  

  • 9. Ohmefentanyl--a new agonist for mu-opiate receptor.
    Xu H; Chen J; Chi ZQ
    Sci Sin B; 1985 May; 28(5):504-11. PubMed ID: 2996128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: evidence for pseudoallosteric modulation.
    Xu H; Kim CH; Zhu YC; Weber RJ; Jacobson AE; Rice KC; Rothman RB
    Neuropharmacology; 1991 May; 30(5):455-62. PubMed ID: 1650928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding properties of 3H-lofentanil at the opiate receptor.
    Gommeren W; Leysen JE
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):171-3. PubMed ID: 6291471
    [No Abstract]   [Full Text] [Related]  

  • 12. Morphiceptin: biphasic inhibition of mu-opiate receptor ligands.
    Villiger JW
    Pharmacol Biochem Behav; 1984 Nov; 21(5):705-6. PubMed ID: 6096895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors.
    Oktem HA; Apaydin S
    Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilized opiate receptors labelled with 3H-lofentanil.
    Ilien B; Gommeren W; Leysen JE; Laduron PM
    Arch Int Pharmacodyn Ther; 1982 Aug; 258(2):313-6. PubMed ID: 6291473
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of chronic treatment of ohmefentanyl stereoisomers on cyclic AMP formation in Sf9 insect cells expressing human mu-opioid receptors.
    Liu ZH; He Y; Jin WQ; Chen XJ; Shen QX; Chi ZQ
    Life Sci; 2004 Apr; 74(24):3001-8. PubMed ID: 15051423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate receptors in brain labelled in vivo with [3H]lofentanil.
    Laduron PM; Poncet J; Janssen PF
    Neuropharmacology; 1985 Jul; 24(7):617-20. PubMed ID: 2862603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
    Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and distribution of mu opioid receptors in rabbit cerebellum.
    Lu YF; Li GF; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):489-91. PubMed ID: 8010044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of three types of opioid binding sites in rat brain in vivo.
    Rosenbaum JS; Holford NH; Richards ML; Aman RA; Sadée W
    Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.